Author | Mark N. Stein, MD

Articles

HDAC Inhibitor Research: Still in Its Infancy

February 15, 2010

Shabason et al have written a thoughtful review of an exciting new class of agents, histone deacetylase (HDAC) inhibitors. While the authors focus primarily on the role of HDAC inhibitors in combination with radiation therapy, we would like to highlight some potential strategies combining these agents with systemic therapies for the treatment of cancer.